BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PLCG1, PLC1, 5335, ENSG00000124181, PLC-II, Plcg1, PLCgamma1, PLC148 AND Treatment
11 results:

  • 1. Adenoid cystic carcinoma of Bartholin's gland, a case report with genomic data and literature review.
    Evin C; Just PA; Borghese B; Fabiano E; Bennani S; Canny E; Marisa L; Derive N; Laurent-Puig P; Alexandre J; Durdux C
    Cancer Radiother; 2023 Jun; 27(4):328-336. PubMed ID: 36759241
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
    Zhang X; Wu Z; Ma K
    BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A New Definition of Pyroptosis-Related Gene Markers to Predict the Prognosis of lung Adenocarcinoma.
    Zhang G; Yan Z
    Biomed Res Int; 2021; 2021():8175003. PubMed ID: 34869771
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR.
    Ghosh S; Nataraj NB; Noronha A; Patkar S; Sekar A; Mukherjee S; Winograd-Katz S; Kramarski L; Verma A; Lindzen M; Garcia DD; Green J; Eisenberg G; Gil-Henn H; Basu A; Lender Y; Weiss S; Oren M; Lotem M; Geiger B; Ruppin E; Yarden Y
    Cell Rep; 2021 May; 35(8):109181. PubMed ID: 34038737
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of 4-bromo-N-(3,5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer.
    Xie Z; Cheng D; Luo L; Shen G; Pan S; Pan Y; Chen B; Wang X; Liu Z; Zhang Y; Ye F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):905-919. PubMed ID: 29734851
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Inhibitory effect of imrecoxib combined with lobaplatin on tumor growth and lymph node metastasis of human lung cancer xenografts in nude mice].
    Wang DC; Wang LC; Wang LJ; Chen G; Zhao YX; Zhao ZF; Li YH
    Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):340-5. PubMed ID: 27188605
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor.
    Hu Z; Hu Y; Liu X; Xi R; Zhang A; Liu D; Xie Q; Chen L
    Oncotarget; 2015 Oct; 6(31):31628-39. PubMed ID: 26375550
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. treatment with a Small Synthetic Compound, KMU-193, induces Apoptosis in A549 Human lung Carcinoma Cells through p53 Up-Regulation.
    Choi EY; Shin KC; Lee J; Kwon TK; Kim S; Park JW
    Asian Pac J Cancer Prev; 2015; 16(14):5883-7. PubMed ID: 26320467
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor.
    Joeckel E; Haber T; Prawitt D; Junker K; Hampel C; Thüroff JW; Roos FC; Brenner W
    Mol Cancer; 2014 Feb; 13():42. PubMed ID: 24576174
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. BAI, a novel cyclin-dependent kinase inhibitor induces apoptosis in A549 cells through activation of caspases and inactivation of Akt.
    Kim S; Lee J; Jang BC; Kwon TK; Park JW
    J Cell Biochem; 2013 Feb; 114(2):282-93. PubMed ID: 22887215
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Phospholipase Cgamma1 is required for metastasis development and progression.
    Sala G; Dituri F; Raimondi C; Previdi S; Maffucci T; Mazzoletti M; Rossi C; Iezzi M; Lattanzio R; Piantelli M; Iacobelli S; Broggini M; Falasca M
    Cancer Res; 2008 Dec; 68(24):10187-96. PubMed ID: 19074886
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.